Drug Facts

Active ingredient(s)	Purpose
Titanium dioxide 11.0%	Sunscreen
Zinc oxide 18.0%	Sunscreen

Uses

helps prevent sunburn
if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

apply liberally 15 minutes before sun exposure
use a water resistant sunscreen if swimming or sweating
reapply at least every 2 hours
children under 6 months: ask a doctor
Sun protection measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses

Inactive ingredients

boron nitride, octyldodecyl stearoyl stearate, glycerin, caprylic/capric triglyceride, magnesium silicate, silica, nylon-12, rosa canina fruit oil, jojoba esters, algae extract, alaria esculenta extract, humic acids, lecithin, betaine, mannitol, stearic acid, diatomaceous earth, zinc sulfate, chlorphenesin. may contain: mica, titanium dioxide, iron oxides, bismuth oxychloride.

Other information

Protect this product from excessive heat and direct sun

Questions or comments?

Call toll free 1-888-795-4747

Dist. by Bare Escentuals Beauty, Inc., SF, CA 94105 USA

PRINCIPAL DISPLAY PANEL - 14 g Carton - R110

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R110

PRINCIPAL DISPLAY PANEL - 14 g Carton - R170

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R170

PRINCIPAL DISPLAY PANEL - 14 g Carton - R130

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R130

PRINCIPAL DISPLAY PANEL - 14 g Carton - R230

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R230

PRINCIPAL DISPLAY PANEL - 14 g Carton - R150

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R150

PRINCIPAL DISPLAY PANEL - 14 g Carton - R210

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R210

PRINCIPAL DISPLAY PANEL - 14 g Carton - R250

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R250

PRINCIPAL DISPLAY PANEL - 14 g Carton - R270

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R270

PRINCIPAL DISPLAY PANEL - 14 g Carton - R310

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R310

PRINCIPAL DISPLAY PANEL - 14 g Carton - R350

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R350

PRINCIPAL DISPLAY PANEL - 14 g Carton - R330

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R330

PRINCIPAL DISPLAY PANEL - 14 g Carton - R410

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R410

PRINCIPAL DISPLAY PANEL - 14 g Carton - R370

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R370

PRINCIPAL DISPLAY PANEL - 14 g Carton - R450

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R450

PRINCIPAL DISPLAY PANEL - 14 g Carton - R430

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R430

PRINCIPAL DISPLAY PANEL - 14 g Carton - R470

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R470

PRINCIPAL DISPLAY PANEL - 14 g Carton - R550

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R550

PRINCIPAL DISPLAY PANEL - 14 g Carton - R570

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R570

PRINCIPAL DISPLAY PANEL - 14 g Carton - R510

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R510

PRINCIPAL DISPLAY PANEL - 14 g Carton - R530

bareMinerals®

net wt 14 g / 0.49 oz.

Principal Display Panel - 14 g Carton - R530

READY FOUNDATION FAIR
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-163
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-163-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION FAIRLY LIGHT
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-164
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-164-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION GOLDEN FAIR
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-165
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-165-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION LIGHT
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-166
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-166-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION FAIRLY MEDIUM
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-167
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-167-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION MEDIUM
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-168
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-168-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION MEDIUM BEIGE
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-169
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-169-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION GOLDEN MEDIUM
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-170
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-170-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION MEDIUM TAN
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-171
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-171-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION TAN
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-172
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-172-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION WARM TAN
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-173
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-173-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION GOLDEN TAN
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-174
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-174-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION DARK
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-175
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-175-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION MEDIUM DARK
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-176
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-176-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION WARM DARK
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-177
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-177-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION GOLDEN DARK
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-178
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-178-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION MEDIUM DEEP
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-179
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-179-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION DEEPEST DEEP
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-180
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-180-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION GOLDEN DEEP
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-181
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-181-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

READY FOUNDATION WARM DEEP
titanium dioxide and zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:98132-182
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	11 g in 100 g
Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z)	Zinc Oxide	18 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
boron nitride (UNII: 2U4T60A6YD)
octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C)
glycerin (UNII: PDC6A3C0OX)
medium-chain triglycerides (UNII: C9H2L21V7U)
magnesium silicate (UNII: 9B9691B2N9)
silicon dioxide (UNII: ETJ7Z6XBU4)
nylon-12 (UNII: 446U8J075B)
rosa canina fruit oil (UNII: CR7307M3QZ)
alaria esculenta (UNII: EJ9JK8J58D)
betaine (UNII: 3SCV180C9W)
mannitol (UNII: 3OWL53L36A)
stearic acid (UNII: 4ELV7Z65AP)
diatomaceous earth (UNII: 2RF6EJ0M85)
zinc sulfate (UNII: 89DS0H96TB)
chlorphenesin (UNII: I670DAL4SZ)
mica (UNII: V8A1AW0880)
ferric oxide red (UNII: 1K09F3G675)
bismuth oxychloride (UNII: 4ZR792I587)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:98132-182-08	14 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	06/01/2012

Labeler - Bare Escentuals Beauty Inc. (087008363)

bareMinerals® Ready Foundation Broad Spectrum SPF 20

Uses

Warnings

Directions

Inactive ingredients

Other information

Questions or comments?

PRINCIPAL DISPLAY PANEL - 14 g Carton - R110

PRINCIPAL DISPLAY PANEL - 14 g Carton - R170

PRINCIPAL DISPLAY PANEL - 14 g Carton - R130

PRINCIPAL DISPLAY PANEL - 14 g Carton - R230

PRINCIPAL DISPLAY PANEL - 14 g Carton - R150

PRINCIPAL DISPLAY PANEL - 14 g Carton - R210

PRINCIPAL DISPLAY PANEL - 14 g Carton - R250

PRINCIPAL DISPLAY PANEL - 14 g Carton - R270

PRINCIPAL DISPLAY PANEL - 14 g Carton - R310

PRINCIPAL DISPLAY PANEL - 14 g Carton - R350

PRINCIPAL DISPLAY PANEL - 14 g Carton - R330

PRINCIPAL DISPLAY PANEL - 14 g Carton - R410

PRINCIPAL DISPLAY PANEL - 14 g Carton - R370

PRINCIPAL DISPLAY PANEL - 14 g Carton - R450

PRINCIPAL DISPLAY PANEL - 14 g Carton - R430

PRINCIPAL DISPLAY PANEL - 14 g Carton - R470

PRINCIPAL DISPLAY PANEL - 14 g Carton - R550

PRINCIPAL DISPLAY PANEL - 14 g Carton - R570

PRINCIPAL DISPLAY PANEL - 14 g Carton - R510

PRINCIPAL DISPLAY PANEL - 14 g Carton - R530